US 10765727
Compositions and methods for producing dendritic cells
granted A61KA61K2039/525A61K2039/5254
Quick answer
US patent 10765727 (Compositions and methods for producing dendritic cells) held by PrimeVax Immuno-Oncology expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrimeVax Immuno-Oncology
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/525, A61K2039/5254, A61K2039/55511, A61K2039/55522